CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog and a growth hormone secretagogue (GHS), developed by ConjuChem Biotechnologies. As a GHRH analog and GHS secretagogue, it stimulates the production and secretion of growth hormone and insulin-like growth factor 1.
CJC-1295’s ability to covalently bind to endogenous serum albumin extends its half-life and duration of action. And the best thing about this peptide is, even though it stimulates the secretion of growth hormone, it does so without impacting its pulsatility. What this means is it won’t disrupt the episodic nature in which GH is secreted.
References: